Relapsed/Refractory Solid Tumor Malignancies or Lymphoma

1 clinical trials · Condition

Record	Firm	Date
Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies (NCT03323398)	ModernaTX, Inc.	2017-08-15

Every clearance here is in the API, with alerts when new ones post.